PMID- 14506699 OWN - NLM STAT- MEDLINE DCOM- 20031204 LR - 20071114 IS - 1045-2257 (Print) IS - 1045-2257 (Linking) VI - 38 IP - 3 DP - 2003 Nov TI - Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization. PG - 249-52 AB - The KG-1 cell line, established from bone marrow cells of a patient with erythroleukemia evolving to acute myelogenous leukemia, and its less differentiated variant, KG-1a, are widely used in research worldwide. However, to our knowledge, neither cell line was studied by use of molecular-cytogenetic techniques such as spectral karyotyping (SKY) and fluorescence in situ hybridization (FISH). Our G-banding, SKY, and FISH analyses revealed a complex karyotype with a pseudodiploid modal chromosome number in both the KG-1 and KG-1a cell lines. The lines shared several identical structural aberrations, including der(4)t(4;8), del(7q), der(8)t(8;12), idic(8)(p11), der(17)t(5;17), and der(20)t(12;20), but also differed with regard to other chromosome rearrangements. In contrast to KG-1, the KG-1a line lost one of the two copies of idic(8)(p11) present in KG-1 cells and gained a der(8;22)(q24;q13), an i(11)(q10), and a der(19)t(14;19)(q13;q13.4). Notably, we have shown that the KG-1 cells harbor a partial hexasomy of the long arm of chromosome 8, which may explain in part the previously reported significantly higher rate of formation of the AML1-ETO fusion gene in KG-1 cells subjected to high-dose gamma irradiation compared with the rates of formation of the BCR-ABL or the DEK-CAN fusion gene. Our detailed description of chromosome rearrangements in KG-1 and KG-1a will be useful for the cytogenetic authentication of the lines, and provide clues as to the regions of the genome that could be studied further to explain the differences in phenotypic properties between KG-1 and KG-1a cells. CI - Copyright 2003 Wiley-Liss, Inc. FAU - Mrozek, Krzysztof AU - Mrozek K AD - Division of Hematology and Oncology, and the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Mrozek-1@medctr.osu.edu FAU - Tanner, Stephan M AU - Tanner SM FAU - Heinonen, Kristiina AU - Heinonen K FAU - Bloomfield, Clara D AU - Bloomfield CD LA - eng GR - 5P30 CA-16058/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Genes Chromosomes Cancer JT - Genes, chromosomes & cancer JID - 9007329 SB - IM MH - Acute Disease MH - Cell Line, Tumor MH - Chromosome Aberrations MH - Chromosome Banding/methods MH - Chromosome Painting/methods MH - Cytogenetic Analysis/*methods MH - Humans MH - In Situ Hybridization, Fluorescence/*methods MH - Karyotyping MH - Leukemia, Myeloid/*genetics MH - Male EDAT- 2003/09/25 05:00 MHDA- 2003/12/05 05:00 CRDT- 2003/09/25 05:00 PHST- 2003/09/25 05:00 [pubmed] PHST- 2003/12/05 05:00 [medline] PHST- 2003/09/25 05:00 [entrez] AID - 10.1002/gcc.10274 [doi] PST - ppublish SO - Genes Chromosomes Cancer. 2003 Nov;38(3):249-52. doi: 10.1002/gcc.10274.